Dysregulated zinc and sphingosine-1-phosphate signaling in pulmonary hypertension: Potential effects by targeting of bone morphogenetic protein receptor type 2 in pulmonary microvessels

Cell Biol Int. 2021 Nov;45(11):2368-2379. doi: 10.1002/cbin.11682. Epub 2021 Aug 15.

Abstract

Recently identified molecular targets in pulmonary artery hypertension (PAH) include sphingosine-1-phosphate (S1P) and zinc transporter ZIP12 signaling. This study sought to determine linkages between these pathways, and with BMPR2 signaling. Lung tissues from a rat model of monocrotaline-induced PAH and therapeutic treatment with bone marrow-derived endothelial-like progenitor cells transduced to overexpress BMPR2 were studied. Multifluorescence quantitative confocal microscopy (MQCM) was applied for analysis of protein expression and localization of markers of vascular remodeling (αSMA and BMPR2), parameters of zinc homeostasis (zinc transporter SLC39A/ZIP family members 1, 10, 12 and 14; and metallothionein MT3) and S1P extracellular signaling (SPHK1, SPNS2, S1P receptor isoforms 1, 2, 3, 5) in 20-200 µm pulmonary microvessels. ZIP12 expression in whole lung tissue lysates was assessed by western blot. Spearman nonparametric correlations between MQCM readouts and hemodynamic parameters, Fulton index (FI), and right ventricular systolic pressure (RVSP) were measured. In line with PAH status, pulmonary microvessels in monocrotaline-treated animals demonstrated significant (p < .05, n = 6 per group) upregulation of αSMA (twofold) and downregulation of BMPR2 (20%). Upregulated ZIP12 (92%), MT3 (57.7%), S1PR2 (54.8%), and S1PR3 (30.3%) were also observed. Significant positive and negative correlations were demonstrated between parameters of zinc homeostasis (ZIP12, MT3), S1P signaling (S1PRs, SPNS2), and vascular remodeling (αSMA, FI, RVSP). MQCM and western blot analysis showed that monocrotaline-induced ZIP12 upregulation could be partially negated by BMPR2-targeted therapy. Our results indicate that altered zinc transport/storage and S1P signaling in the monocrotaline-induced PAH rat model are linked to each other, and could be alleviated by BMPR2-targeted therapy.

Keywords: BMPR2; ZIP12; pulmonary arterial hypertension; sphingosine-1-phosphate; zinc dyshomeostasis.

MeSH terms

  • Animals
  • Bone Morphogenetic Protein Receptors, Type II / metabolism*
  • Cation Transport Proteins / metabolism*
  • Cells, Cultured
  • Disease Models, Animal
  • Hypertension, Pulmonary / metabolism*
  • Hypertension, Pulmonary / physiopathology
  • Lung / metabolism
  • Lysophospholipids / metabolism
  • Male
  • Microvessels / metabolism
  • Monocrotaline / pharmacology
  • Myocytes, Smooth Muscle / metabolism
  • Pulmonary Artery / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism
  • Sphingosine-1-Phosphate Receptors / metabolism*
  • Vascular Remodeling
  • Zinc / metabolism

Substances

  • Cation Transport Proteins
  • Lysophospholipids
  • S1PR1 protein, rat
  • Slc39a12 protein, rat
  • Sphingosine-1-Phosphate Receptors
  • sphingosine 1-phosphate
  • Monocrotaline
  • Bone Morphogenetic Protein Receptors, Type II
  • Zinc
  • Sphingosine